Vitamin D supplementation for chronic liver diseases in adults

CONCLUSIONS: Given the high risk of bias and insufficient power of the included trials and the very low certainty of the available evidence, vitamin D supplementation versus placebo or no intervention may increase or reduce all-cause mortality, liver-related mortality, serious adverse events, or non-serious adverse events in adults with chronic liver diseases. There is a lack of data on liver-related morbidity and health-related quality of life. Further evidence on clinically important outcomes analysed in this review is needed.PMID:34431511 | DOI:10.1002/14651858.CD011564.pub3
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Source Type: research